Cover Image

Response to cabozantinib following acquired entrectinib resistance in a patient with ETV6-NTRK3 fusion-positive carcinoma harboring the NTRK3G623R solvent-front mutation

Saved in:
Bibliographic Details
Main Authors: Hanf, Dorothea (Author) , Heining, Christoph (Author) , Laaber, Karin (Author) , Nebelung, Heiner (Author) , Uhrig, Sebastian (Author) , Hutter, Barbara (Author) , Jahn, Arne (Author) , Richter, Daniela (Author) , Aust, Daniela (Author) , Herbst, Friederike (Author) , Fröhling, Stefan (Author) , Glimm, Hanno (Author) , Folprecht, Gunnar (Author)
Format: Article (Journal)
Language:English
Published: April 22, 2021
In: JCO precision oncology
Year: 2021, Volume: 5, Pages: 687-694
ISSN:2473-4284
DOI:10.1200/PO.20.00278
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO.20.00278
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/PO.20.00278
Get full text
Author Notes:Dorothea Hanf, MD; Christoph Heining, MD; Karin Laaber, MSc; Heiner Nebelung, MD; Sebastian Uhrig, MSc; Barbara Hutter, PhD; Arne Jahn, MD; Daniela Richter, PhD; Daniela Aust, MD; Friederike Herbst, PhD; Stefan Fröhling, MD; Hanno Glimm, MD; and Gunnar Folprecht, MD
Description
Item Description:Im Text ist "G623R" hochgestellt
Gesehen am 10.03.2023
Physical Description:Online Resource
ISSN:2473-4284
DOI:10.1200/PO.20.00278

Similar Items